1. bookVolume 68 (2018): Edizione 2 (June 2018)
Dettagli della rivista
License
Formato
Rivista
eISSN
1846-9558
Prima pubblicazione
28 Feb 2007
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese
Accesso libero

Development and evaluation of orally disintegrating tablets containing the mosapride resin complex

Pubblicato online: 26 Apr 2018
Volume & Edizione: Volume 68 (2018) - Edizione 2 (June 2018)
Pagine: 159 - 170
Accettato: 15 Jan 2018
Dettagli della rivista
License
Formato
Rivista
eISSN
1846-9558
Prima pubblicazione
28 Feb 2007
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese

1. M. Ruth, B. Hamelin, K. Röhss and L. Lundell, The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease, Aliment. Pharm. Ther.12 (1998) 35–40; https://doi.org/10.1046/j.1365-2036.1998.00268.x10.1046/j.1365-2036.1998.00268.x9692698Search in Google Scholar

2. Y. Takayuki, T. Hiroaki, M. Atsushi, K. Masataka, S. Kazuhiro and U. Takahiro, Mechanism of controlled drug release from a salting-out taste-masking system, J. Control. Release131 (2008) 47–53; https://doi.org/10.1016/j.jconrel.2008.07.00910.1016/j.jconrel.2008.07.00918680773Search in Google Scholar

3. A. Siddiqui, R. B. Shah and M. A. Khan, Oseltamivir phosphate-amberlite(TM) IRP 64 ioniccomplexfor taste masking: preparation and chemometric evaluation, J. Pharm. Sci.102 (2013) 1800–1812; https://doi.org/10.1002/jps.2351810.1002/jps.2351823559456Search in Google Scholar

4. R. B. Shah, M. A. Tawakkul, V. A. Sayeed and M. A. Khan, Complexation between risperidone and amberlite resin by various methods of preparation and binding study, Drug Dev. Ind. Pharm.35 (2009) 1409–1418; https://doi.org/10.3109/0363904090293924710.3109/0363904090293924719929200Search in Google Scholar

5. Z. Z. Ge, M. Y. Yang, Y. L. Wang, L. Shan and C. S. Gao, Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin, Drug Dev. Ind. Pharm.41 (2015) 934–941; https://doi.org/10.3109/03639045.2014.91452910.3109/03639045.2014.91452924785576Search in Google Scholar

6. W. Samprasit, P. Opanasopit, P. Akkaramongkolporn, T. Ngawhirunpat, K. Wongsermsina and S. Panomsuka, Preparation and evaluation of taste-masked dextromethorphan oral disintegrating tablet, Pharm. Dev. Technol.17 (2012) 315–320; https://doi.org/10.3109/10837450.2010.53582810.3109/10837450.2010.53582821142821Search in Google Scholar

7. E. Roblegg, P. Dittrich, K. Haltmeyer and A. Zimmer, Reformulation of a codeine phosphate liquid controlled-release product, Drug Dev. Ind. Pharm.36 (2010) 1454–1462; https://doi.org/10.3109/03639045.2010.48787010.3109/03639045.2010.48787020533890Search in Google Scholar

8. M. Preis, L. Grother, P. Axe and J. Breitkreutz, In-vitro and in-vivo evaluation of taste-masked cetirizine hydrochloride formulated in oral lyophilisates, Int. J. Pharm. 491 (2015) 8–16; https://doi.org/10.1016/j.ijpharm.2015.06.00210.1016/j.ijpharm.2015.06.00226051543Search in Google Scholar

9. C. P. Yewale, M. N. Rathib, G. G. Koreb, G. V. Jadhava and M. P. Wagha, Formulation and development of taste masked fast-disintegrating tablets (FDTs) of chlorpheniramine maleate using ion-exchange resins, Pharm. Dev. Technol.18 (2013) 367–376; https://doi.org/10.3109/10837450.2011.62787010.3109/10837450.2011.62787022023351Search in Google Scholar

10. P. Akkaramongkolporn, T. Ngawhirunpat and P. Opanasopit, Preparation and evaluation of differently sulfonated styrene-divinylbenzene cross-linked copolymer cationic exchange resins as novel carriers for drug delivery, AAPS PharmSciTech.10 (2009) 641–648; https://doi.org/10.1208/s12249-009-9259-510.1208/s12249-009-9259-5269081919452281Search in Google Scholar

11. A. Siddiqui, R. B. Shah and M. A. Khan, Oseltamivir phosphate-amberlite (TM) IRP 64 ionic complex for taste masking: Preparation and chemometric evaluation, J. Pharm. Sci.102 (2013) 1800–1812; https://doi.org/10.10.1002/jps.23518Search in Google Scholar

12. D. Shukla, S. Chakraborty, S. Singh and B. Mishra, Fabrication and evaluation of taste masked resinate of risperidone and its orally disintegrating tablets, Chem. Pharm. Bull.57 (2009) 337–345; https://doi.org/10.1248/cpb.57.33710.1248/cpb.57.337Search in Google Scholar

13. M. A. Tawakkul, R. B. Shah, A. Zidan, V. A. Sayeed and M. A. Khan, Complexation of risperidone with a taste-masking resin: Novel application of near infra-red and chemical imaging to evaluate complexes, Pharm. Dev. Technol.14 (2009) 409–421; https://doi.org/10.1080/1083745080271266610.1080/10837450802712666Search in Google Scholar

14. V. K. Suhagiya, A. N. Goyani and R. N. Gupta, Taste masking by ion exchange resin and its new applications: A review, Int. J. Pharm. Sci. Res.1 (2010) 22–37; https://doi.org/10.13040/IJPSR.0975-8232.1(4).22-3710.13040/IJPSR.0975-8232.1(4).22-37Search in Google Scholar

15. S. Patra, R. Samantaray, S. Pattnaik and B. Barik, Taste masking of Etoricoxib by using ion-exchange resin, Pharm. Dev. Technol.15 (2010) 511–517; https://doi.org/10.3109/1083745090332278710.3109/1083745090332278719845450Search in Google Scholar

16. A. Solaiman, A. S. Suliman, S. Shinde, S. Naz and A. A. Elkordy, Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscarmellose sodium and Disintequick MCC-25, Int. J. Pharm. 501 (2016) 87–95; https://doi.org/10.1016/j.ijpharm.2016.01.06510.1016/j.ijpharm.2016.01.06526827922Search in Google Scholar

17. M. Sugimoto, K. Matsubara, Y. Koida and M. Kobayashi, The preparation of rapidly disintegrating tablets in the mouth, Pharm. Dev. Technol.6 (2001) 487–493; https://doi.org/10.1081/PDT-12000028710.1081/PDT-12000028711775950Search in Google Scholar

18. Y. Kuno, K. Masazumi, S. Ando and H. Nakagami, Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols, J. Control. Release105 (2005) 16–22; https://doi.org/10.1016/j.jconrel.005.01.018Search in Google Scholar

19. B. Daihom, A. Alayoubi, D. J. Ma, L. J. Wang, S. Mishra, R. Helms and H. Almoazen, Development and physicochemical characterization of clindamycin resinate for taste masking in pediatrics, Drug Dev. Ind. Pharm. 42 (2016) 1600–1608; https://doi.org/10.3109/03639045.2016.116010410.3109/03639045.2016.116010426928944Search in Google Scholar

20. H. Sohi, Y. Sultana and R. K. Khar, Taste masking technologies in oral pharmaceuticals: recent developments and approaches, Drug Dev. Ind. Pharm.30 (2004) 429–448; https://doi.org/10.1081/DDC-12003747710.1081/DDC-120037477Search in Google Scholar

21. C. de C Bergamaschi, L. A. Berto, P. C. Venâncio, K. Cogo, M. Franz-Montan, R. H. L. Motta, M. P. Santamaria and F. C. Groppo, Concentrations of metronidazole in human plasma and saliva after tablet or gel administration, J. Pharm. Pharmacol.66 (2014) 40–47; https://doi.org/10.1111/jphp.1216110.1111/jphp.1216124341948Search in Google Scholar

22. F. Gut, W. Schiek, W. E. Haefeli, I. Walter-Sack and J. Burhenne, Cation exchange resins as pharmaceutical carriers for methylene blue: binding and release, Eur. J. Pharm. Biopharm.69 (2008) 582–587; https://doi.org/10.1016/j.ejpb.2007.12.01610.1016/j.ejpb.2007.12.01618226881Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo